Caidya Announces Strategic Combination with Simbec-Orion — Learn more here

LinkedIn

+44 (0) 1753 578 080

[email protected]

About Us

About Us

Click to visit About Us page

Who We Are

Drug Development Advisory Board

Our Mission, Vision & Values

Our Clients

ESG

Corporate Policies

Events
Our Services

Our Services

Click to visit Our Services page

Early Stage Consultancy Services

Clinical Trial Management Services

Clinical Trial Management Services

Click to visit overview page

Phase I Phase II Phase III Site Management & Monitoring IMP Management Biometric Services

Central Laboratory Services

Central Laboratory Services

Click to visit overview page

Bioanalytical Laboratory Services Routine Safety Testing Immunoassays

Clinical Pharmacology

Scintigraphy

Pharmacovigilance

Regulatory Affairs

Clinical & Medical Writing

Data Quality, Security & Compliance

SMO Services
Our Expertise

Our Expertise

Click to visit Our Expertise page

Early Stage Consultancy Services

First in Human

Phase II

Phase III

AI : Causal Modeling

Respiratory therapeutics

CNS Indications

Oncology, including Rare Oncology

Rare & Ultra-Rare Disease Trials

Addiction & Risk Reduction Research
Resources

Resources

Click to visit Resources page

Blog

Webinars

Brochures

White papers

Videos

Case Studies

Clinical Trial Publications
Latest News
Join Our Team
Contact

About Us

About Us

Click to visit About Us page

Who We Are

Drug Development Advisory Board

Our Mission, Vision & Values

Our Clients

ESG

Corporate Policies

Events
Our Services

Our Services

Click to visit Our Services page

Early Stage Consultancy Services

Clinical Trial Management Services

Clinical Trial Management Services

Click to visit overview page

Phase I Phase II Phase III Site Management & Monitoring IMP Management Biometric Services

Central Laboratory Services

Central Laboratory Services

Click to visit overview page

Bioanalytical Laboratory Services Routine Safety Testing Immunoassays

Clinical Pharmacology

Scintigraphy

Pharmacovigilance

Regulatory Affairs

Clinical & Medical Writing

Data Quality, Security & Compliance

SMO Services
Our Expertise

Our Expertise

Click to visit Our Expertise page

Early Stage Consultancy Services

First in Human

Phase II

Phase III

AI : Causal Modeling

Respiratory therapeutics

CNS Indications

Oncology, including Rare Oncology

Rare & Ultra-Rare Disease Trials

Addiction & Risk Reduction Research
Resources

Resources

Click to visit Resources page

Blog

Webinars

Brochures

White papers

Videos

Case Studies

Clinical Trial Publications
Latest News
Join Our Team
Contact

LinkedIn

+44 (0) 1753 578 080

[email protected]

Search for:

Step Inside Clinical Research: Simbec-Orion Open Day

October 21, 2026

Back to Blog Archive

Back to Blog Archive

About Us

Simbec-Orion is an experienced, technology-enabled, global Contract Research Organisation (CRO) specialising in Clinical Pharmacology, Oncology, and Rare Diseases, with offices across the UK, Europe, the United States and Asia-Pacific. Established for almost 50 years, we provide clinical trial expertise to a wide range of small to mid-sized biotech and pharmaceutical partners around the world.

Across the organisation, scientific teams leverage both a wide therapeutic experience in clinical pharmacology, as well as more specialist expertise in Phase I-IV oncology and rare disease. Simbec-Orion’s adaptable, highly experienced teams continuously take a quality-first approach, whilst maintaining the short communication lines and Senior Leadership Team oversight only achievable with a lean management structure.

CRO Services

Central Laboratory Services

Clinical Trial Management

Clinical Pharmacology

Regulatory Affairs

Clinical & Medical Writing

Therapeutic Services

Explore

Covid-19 Workplace Risk Assessment

Contact Us

[email protected]

+44 (0) 1753 578 080

Simbec-Orion Group Ltd
Simbec House,
Merthyr Tydfil Industrial Park,
Pentrebach, Merthyr Tydfil,
CF48 4DR,
United Kingdom

© Simbec-Orion

Site designed and built by The SEO Works